We found that several features are associated with specific breast cancer subtypes, predominantly between non-luminal (HER-2 enriched and TNBC) and luminal-like subtypes, between positive and negative ER and PR receptor statuses, tumour grades, LVI, and ALN. This evidence concerns the gene ERBB2 and breast carcinoma.